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Peptidylarginine deiminase 
1-catalyzed histone citrullination 
is essential for early embryo 
development
Xiaoqian Zhang1,*, Xiaoqiu Liu2,3,*, Mei Zhang1, Tingting Li1, Aaron Muth4, Paul R. Thompson4, 
Scott A. Coonrod5 & Xuesen Zhang1
Peptidylarginine deiminase (PADI) enzymes are increasingly being associated with the regulation of 
chromatin structure and gene activity via histone citrullination. As one of the PADI family members, 
PADI1 has been mainly reported to be expressed in the epidermis and uterus, where the protein in 
keratinocytes is thought to promote differentiation by citrullinating filament proteins. However, 
the roles of PADI1 in preimplantation development have not been addressed. Using a PADI1-specific 
inhibitor and Padi1-morpholino knockdown, we found that citrullination of histone tails at H4R3 and 
H3R2/8/17 were markedly reduced in the 2- and 4-cell embryos. Consistent with this observation, 
early embryo development was also arrested at the 4-cell stage upon depletion of PADI1 or inhibition 
of PADI1 enzyme activity. Additionally, by employing 5-ethynyl uridine (EU) incorporation analysis, 
ablation of PADI1 function led to a dramatic decrease in overall transcriptional activity, correlating 
well with the reduced levels of phosphorylation of RNA Pol II at Ser2 observed at 2- or 4-cell stage of 
embryos under Padi1 knockdown or inhibiting PADI1. Thus, our data reveal a novel function of PADI1 
during early embryo development transitions by catalyzing histone tail citrullination, which facilitates 
early embryo genome transactivation.
During preimplantation development, mammalian embryos undergo robust and dynamic changes in their 
gene expression patterns1–4. In the mouse, transcription from the newly formed zygotic genome, also known 
as embryonic genome activation (EGA), mainly occurs at the 2-cell stage. This first major transition promotes 
the generation of novel transcripts that are not expressed in oocytes5–9. A second wave of new gene transcripts, 
named mid-preimplantation gene activation, appears between the 4-cell and 8-cell stages, and are involved in the 
beginning of compaction2,4,10,11, followed by the dynamic morphological and functional changes from the morula 
to blastocyst stage5,12. Though accumulating efforts have been focused on identifying maternal and embryonic 
transcripts involved in early embryo development, the potential underlying factors controlling these two wave 
transitions still remain to be explored.
Peptidylarginine deiminases (PADIs) are a family of calcium dependent enzymes that convert positively 
charged arginine residues to citrulline via a hydrolytic process termed citrullination or deimination13. This 
post-translational modification alters protein charge resulting in changes in protein structure, function, and 
molecular interactions14. There are five PADI family members, PADI1-4 and PADI6. Each PADI enzyme has a 
unique tissue distribution pattern and distinct substrate specificity, except for PADI6 which does not appear to 
have catalytic activity15. PADI-mediated histone citrullination is increasingly being associated with the regula-
tion of chromatin structure and gene activity. For example, we recently found that PADI2-catalyzed histone H3 
arginine 26 citrullination leads to chromatin decondensation and transcriptional activation in human breast 
cancer MCF7 cells16. PADI2 also targets histone H3 arginine 2/8/17 for citrullination in mammary epithelial 
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cells and appears to regulate the expression of lactation related genes in mammary epithelial cells17. PADI4 
regulates the proliferation of multipotent progenitors in the bone marrow by controlling c-myc expression 
through catalyzing the citrullination of histone H3 on its promoter18. In addition to histone H3 citrullination, 
PADI4-catalyzed histone H4 arginine 3 citrullination at the TFF1 promoter in MCF7 cells appears to regulate its 
expression19. Citrullination of histone H1 mediated by PADI4 at promoter elements can also promote localized 
chromatin decondensation in stem cells, thus regulating the pluripotent state20. These observations suggest that 
PADI-mediated histone citrullination profoundly affects chromatin structure and regulates chromatin-based 
activities.
Interestingly, a potential role for histone citrullination in chromatin-based activities during preimplantation 
development has also been investigated21. In that report, the specific arginine residues on the histone H3 and 
H4 N-terminal tails (H4R3, H3R2/8/17) were citrullinated and showed a unique localization pattern during 
early development. Inhibiting histone citrullination at the pronuclear stage zygotes blocked embryonic devel-
opment beyond the 4-cell stage. However, it was not clear which PADI catalyzes histone tail citrullination in 
preimplantation development and the underlying mechanism is far from complete. In this study, by employing a 
PADI1-specific inhibitor and morpholino knockdown, we showed that inhibition of PADI1 activity and depletion 
of PADI1 suppress histone tail citrullination and genome transactivation in mouse early embryos, thus leading to 
preimplantation development arrest at 4-cell stage.
Results
Cellular localization of PADI1 in mouse oocyte and during preimplantation embryo development. 
To look for which PADI family member may mediate histone tail citrullination in early embryo development, 
we first analyzed the expression pattern of PADI1 in mouse oocytes and throughout early embryo development 
by immunofluorescent staining coupled with confocal microscopy. As shown in Fig. 1A, PADI1 protein was 
predominantly localized in the nuclei of germinal vesicle (GV) and metaphase II (MII) oocytes. With a gradual 
decrease of expression in pronuclear (PN) stage of zygotes, PADI1 started to accumulate dramatically in the 
nuclei of embryos from the 2-cell stage, and this intense fluorescent staining for PADI1 was observed in the nuclei 
of 4-cell embryos, 8-cell embryos, morula, and blastocyst. This expression pattern indicated that PADI1 might 
play an important role in early embryo development, especially starting at 2- or 4-cell stage. To further confirm 
the anti-PADI1 antibody specificity, an overexpressed Flag-tagged or His-tagged version of PADI1 was readily 
detected in HEK293 cell extracts by western blot using anti-PADI1 antibody, while this antibody does not rec-
ognize other PADI family members in the lysates of HEK293 cells that had been transfected with Flag-PADI2, 
Flag-PADI4, or His-PADI3 tagged expression vectors (Supplementary Fig. S1). We also examined the expression 
and localization of the other PADI family members in mouse oocytes and early embryos during all stages of 
development. Unlike PADI1, expression of PADI2, PADI3, or PADI4 protein mainly localized to the cytoplasm of 
the oocytes and preimplantation embryos (Fig. 1B–D), with only slight immunofluorescence signals for PADI2 
and PADI3 observed in the nuclei of GV oocytes (Fig. 1B,C), and occasional weak nuclear expression of PADI3 in 
the morula and blastocyst (Fig. 1C). PADI6 was not tested here given that PADI6 only localizes in the cytoplasm 
of germ cells and embryos, and PADI6 does not have enzyme catalytic activity15. These results suggest that PADI1 
may function as a predominant nuclear PADI in mouse preimplantation embryos. Such a distribution pattern 
of PADI1 prompted us to explore its potential roles in mouse oocyte maturation and during preimplantation 
embryo development.
Inhibiting PADI1 enzyme activity or depletion of PADI1 compromises early embryo development. 
We next wished to assess the function of PADI1 at the beginning of the mouse embryo development. To this 
end, we used two methods: inhibition of PADI1 enzyme activity and injection of Padi1-targeting morpholino 
(Padi1-MO). Previous studies have shown that inhibiting PADI activity in the mouse early embryos using 250 μ M 
of the pan-PADI inhibitor, Cl-amidine, blocked early cleavage divisions in vitro, with embryos mainly arrested at 
the 2- and 4-cell stages21. We found that specifically inhibiting PADI1 activity with 100 μ M of the PADI1-specific 
inhibitor D-Cl-amidine, a next generation Cl-amidine analogue22, did not affect oocyte maturation or pronu-
clear formation. Zygotes cultured under 100 μ M D-Cl-amidine successfully proceeded through the first two 
cleavages and reached the 4-cell stage, at the same time as that in the phosphate-buffered saline (PBS) control 
group (Fig. 2A). However, no zygotes were found to have progressed beyond the 4-cell stage of development 
(0%, n = 357) while 75% of embryos (n = 392) cultured in KSOM media supplemented with PBS developed to 
the morula or blastocyst (Fig. 2B and Table 1). To exclude the possibility that D-Cl-amidine blocked develop-
ment is due to a non-specific toxic side-effect, we examined embryo viability following D-Cl-amidine treatment 
using the vital dye propidium iodide (PI). PI is excluded by viable cells but can penetrate cell membranes of 
dying or dead cells to intercalate into double-stranded nucleic acids. PN zygotes were cultured for 68 hours in 
KSOM medium supplemented with 100 μ M D-Cl-amidine or PBS. Embryos were then fixed and mounted on 
glass slides for confocal laser scanning microscope analysis. Results showed that nuclei from D-Cl-amidine 
treated (arrested at 4-cell stage) or PBS treated embryos (developed to 8-cell stage) were not stained with PI while 
nuclei from D-Cl-amidine treated embryos followed by 0.1% Triton extraction were strongly stained with PI 
(Supplementary Fig. S2). These results suggest that D-Cl-amidine treatment does not affect cell membrane health, 
therefore early embryo development arrest is likely due to the specific inhibition of PADI1 activity.
For depletion of PADI1, we injected Padi1-MO into the zygotes. A non-targeting MO was injected as a neg-
ative control. A significant reduction of PADI1 protein level in the 2- and 4-cell embryos was confirmed by 
immunofluorescence staining (P < 0.05) (Fig. 2C) and western blotting (Fig. 2D). We found that the majority of 
the embryos injected with Padi1-MO arrested at the 4-cell stage (82.72%, n = 81), with only 9.87% (n = 81) of 
the embryos developing beyond the morula and blastocyst stages. In sharp contrast, 50% (n = 80) of the control 
embryos developed beyond the morula stage (Fig. 2E and Table 2). Thus, injection of Padi1-MO, similarly to 
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PADI1 inhibition, caused the majority of embryos to arrest at the 4-cell stage. Together, these findings suggest that 
PADI1 activity is required for progression of embryonic development beyond the 4-cell stage.
Inhibiting PADI1 or depletion of PADI1 suppresses citrulline levels on histone tails in early 
embryos. A previous report has demonstrated the robust citrullination of histone H3 and H4 tails from 2-cell 
to blastocyst stage during preimplantation development21. Given that PADI1 is the dominant nuclear PADI in 
early embryos, and that PADI1 showed similar spatiotemporal expression pattern with that of the histone tail 
citrullination during preimplantation development, we asked whether PADI1 catalyzes histone tail citrullination 
in the early embryos. To this end, we first confirmed that PADI1 targeted histone tails for citrullination in vitro. 
Purified Flag-tagged PADI1 protein from Flag-PADI1 overexpression HEK293 cells (Fig. 3A) was used to citrul-
linate bulk histones. Immunoblotting the resolved histones with H3Cit2/8/17 and H4Cit3 antibodies showed that 
these two antibodies were reactive with an appropriately sized band from the PADI1-citrullinated histones but 
was not reactive with untreated histones (Fig. 3B).
Next, we tested whether D-Cl-amidine suppressed citrulline levels on histones in early embryos using 
the H3Cit2/8/17 and H4Cit3 antibodies. PN zygotes were cultured in KSOM media supplemented with-
out or with 100 μ M D-Cl-amidine. Embryos collected at the 2- and 4-cell stages were fixed, stained with the 
anti-citrullinated histone antibodies and then evaluated by laser scanning confocal microscopy. Results showed 
that staining levels for the H4Cit3 and H3Cit2/8/17 antibodies were reduced significantly compared to the 
KSOM control group (P < 0.05) (Fig. 3C,D). To further test whether histone citrullination could be eliminated 
by higher concentration of D-Cl-amidine, we cultured PN zygotes in KSOM media supplemented with 200 uM 
D-Cl-amidine and collected at the 4-cell stage for the following immunostaining. Results showed that the 
Figure 1. Immunofluorescence staining of PADI1, PADI2, PADI3, and PADI4. Mouse oocytes at GV, 
metaphase II, and preimplantation embryos at different stages (1-cell embryos (PN), 2-cell embryos, 4-cell 
embryos, 8-cell embryos, morula, and blastocyst) were immunostained with antibodies specific for PADI1  
(A), PADI2 (B), PADI3 (C), and PADI4 (D), respectively, and counterstained with DAPI for nuclear staining 
(red). Scale bar, 20 μ m.
www.nature.com/scientificreports/
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Figure 2. Inhibiting PADI1 activity or ablation of PADI1 blocks embryonic development in vitro beyond 
4-cell stage. (A) D-Cl-amidine treatment did not affect the rate of oocyte maturation (n = 285, the controls and 
n = 239, D-Cl-amidine treatment), zygote to 2-cell (n = 339, the controls and n = 342, D-Cl-amidine treatment), 
and 2-cell to 4-cell transitions (n = 402, the controls and n = 330, D-Cl-amidine treatment). (B) Pronuclear 
stage zygotes were cultured in KSOM medium supplemented without (n = 392) or with 100 μ M D-Cl-amidine 
(n = 357) and no embryo developed to the morula or blastocyst stage. The lower panel showing the representative 
embryos observed by light microscopy. (C) Immunostaining confirmed that nuclear PADI1 expression 
significantly decreased in Padi1-MO-injected embryos at the 2- or 4-cell stage compared to the control embryos 
(P < 0.05). DNA was counterstained with DAPI. Scale bar, 20 μ m. (D) The efficiency of Padi1-MO was verified by 
Western blot. Band intensity was calculated using ImageJ software, and the ratio of PADI1/GAPDH expression 
was normalized. (E) Depletion of PADI1 led to developmental arrest. PN zygotes were injected with Padi1-MO 
(n = 81) or Control-MO (n = 80), and cultured until the blastocyst stage. The embryos from each experimental 
group were counted and scored according to their developmental stage. Shown is the percentage of morula and 
blastocyst embryos from three independent experiments. *P < 0.05.
Group No.
Stage of embryos (%)
≤4-cell 8-cell ≥Morula
Control 392 88 (22.45%) 10 (2.55%) 294 (75.0%)
D-Cl-amidine 357 357 (100%) 0 0
Table 1.  The effect of D-Cl-amidine on early embryonic development.
Group No.
Stage of embryos (%)
≤4-cell 8-cell ≥Morula
Control 80 33 (41.25%) 7 (8.75%) 40 (50.0%)
Padi1-MO 81 67 (82.72%) 6 (7.41%) 8 (9.87%)
Table 2.  The effect of Padi1-MO injection on early embryonic development.
www.nature.com/scientificreports/
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H3Cit2/8/17 and H4Cit3 staining signals were reduced to undetectable levels compared to the KSOM control 
group (Supplementary Fig. S3). Similarly, injection of the Padi1-MO into zygotes also reduced histone H4Cit3 
and H3Cit2/8/17 levels at 2- and 4-cell stages (Fig. 3E,F). These results strongly suggest that PADI1 can catalyze 
histone H3 and H4 tail citrullination in early embryos, which may facilitate gene expression in preimplantation 
development.
Ablation of PADI1 function leads to a dramatic decrease of genome transactivation. Changes in 
chromatin structure are thought to play an important role in reprogramming gene expression during preimplan-
tation development23–25. We postulated that the observed decrease in histone citrullination in PADI1-depleted 
or D-Cl-amidine-treated embryos could inhibit genome transactivation at 2–4 cell stages, thus leading to early 
embryo development arrest. To test his hypothesis, we exploited 5-ethynyl uridine (EU) incorporation in living 
cells followed by “click chemistry” to detect populations of newly synthesized RNA26. EU, an alkyne-modified 
nucleotide, when incubated with the live cells, can be actively incorporated into nascent RNA. Therefore, PN 
zygotes were cultured in KSOM media supplemented without or with 100 μ M D-Cl-amidine. Before embryo 
Figure 3. Inhibiting or knockdown PADI1 decreases histone citrullination in mouse 2-cell and 4-cell stage 
of embryos. (A) Silver staining of the Flag-tagged PADI1 protein purified from Flag-PADI1 overexpressed 
HEK293 cells. (B) Western blotting showing the anti-H3Cit2/8/17 and anti-H4Cit3 antibodies specifically 
reactive with the appropriately sized band from PADI1-treated bulk histones but not from nontreated 
histones. Anti-histone H4 staining revealed the presence of approximately equal amounts of histone in 
each lane. (C–F) PN zygotes were cultured in KSOM medium for 24 h (2-cell stage) and 48 h (4-cell stage) 
supplemented with 100 μ M D-Cl-amidine or equal volume of PBS as a control. Embryos were collected and 
fixed for further immunofluorescence staining with anti-H3Cit2/8/17 and anti-H4Cit3 antibodies, respectively. 
DNA was counterstained with DAPI. Scale bar, 20 μ m. Representative images and quantification of the 
immunofluorescence signals from each group are shown. At least 40 embryos at each stage for each group were 
analyzed, and the experiments were repeated 3 times. Error bars indicate mean ± SD. *P < 0.05 vs. controls.
www.nature.com/scientificreports/
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collection, 1 mM EU was added to the culture medium and incubated for another 3 hours. Then embryos at 
2- and 4-cell stages were collected and fixed, followed by immunofluorescence analysis. As shown in Fig. 4, EU 
incorporation was readily detected in the early embryos in the control groups. However, D-Cl-amidine treatment 
or Padi1-MO injection significantly decreased EU incorporation, indicating a decrease of overall transcriptional 
activity (P < 0.05). It has been documented that several stage-specific genes involved in embryo developmental 
are actively transcribed after 4-cell stages3. Therefore, we further analyzed the expression of some of these genes 
in both control and D-Cl-amidine treated 4-cell embryos. Compared with the control embryos, D-Cl-amidine 
treated embryos displayed significantly decreased expression of Pou5f1. Expression of the rest of the genes 
(Eomes, Crtr-1, Utf1) was not significant as a result of the large variation, but the expression was still obviously 
lower in D-Cl-amidine treated embryos (Supplementary Fig. S4), further confirming that PADI1-enzyme activity 
is required for genome transactivation at 2–4 cell stages.
Hypophosphorylation of RNA Pol II Ser2 in D-Cl-amidine-treated or PADI1-depleted 2- and 4-cell 
early embryos. Phosphorylated (Ser2) RNA polymerase II (RNA Pol II) is a well-characterized marker for 
active transcription, and has been proposed as a landmark of zygotic gene activation in early embryos27. To gain 
more insight into the molecular mechanism underlying the dramatic decrease in genome transactivation in 2- and 
4-cell stage of embryos upon inhibition or depletion of PADI1, we analyzed whether RNA Pol II Ser2 phospho-
rylation levels in these arrested embryos were affected. Results showed a statistically significant, ~30–40% reduc-
tion of RNA Pol II phosphorylation at Ser2 in D-Cl-amidine-treated embryos at 2- and 4-cell stages (P < 0.05). 
However, this treatment did not seem to change the total level of RNA Pol II (Fig. 5A). As expected, knockdown 
of Padi1 through Padi1-MO injection also significantly decreased the RNA Pol II phosphorylation at both stages 
(P < 0.05) (Fig. 5B). Together, these results further confirmed our hypothesis that inhibiting PADI1 activity or 
knockdown of Padi1 in 2- or 4-cell stage of embryos reduced histone H4Cit3 and H3Cit2/8/17, which may in turn 
disturb the local chromatin conformation, contributing to, at least in part, the hypophosphorylation of RNA Pol 
II Ser2 and resulting in the decrease of overall transcriptional activity in preimplantation development.
Figure 4. Immunofluorescence staining for EU incorporation. Representative confocal images 
demonstrating a significant decrease of EU positive nuclear signals in the 2- or 4-cell stage of embryos treated 
with D-Cl-amidine (A) or Padi1-MO injection (B), compared with the control embryos, respectively. DNA was 
stained with Hoechst 33342 (red). Scale bar, 20 μ m. Histogram on the right panel showing the quantification of 
EU incorporation data. Error bars indicate mean ± SD from 3 independent experiments. *P < 0.05 vs. controls.
www.nature.com/scientificreports/
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Discussion
Multiple posttranslational modifications of histone tails have been identified as the key epigenetic marks to cor-
relate with gene expression patterns during the preimplantation development transitions, including acetylation, 
methylation, ubiquitination28–31. These modifications influence gene transcriptional outcome by modulating local 
chromatin structure, allowing a more permissive chromatin state, and facilitating transcription32. More recently, 
histone citrullination of histone H4R3 and H3R2/8/17 has also been found robustly activated in the nuclei in pre-
implantation embryos, suggesting that PADI-mediated histone citrullination may play an important role in early 
development21. However, it was not clear which PADI catalyzed these modifications. We first excluded PADI6 
since PADI6 does not contain enzyme activity15. We next excluded the possibility of PADI2 and PADI4, as H4Cit3 
and H3cit2/8/17 did not show any appreciable loss in these two mutant mouse lines15 (Supplementary Fig. S5). 
Studies from Brahmajosyula et al.33 has detected nuclear PADI4 and citrullinated histone H3 in mouse embryos, 
Figure 5. Effect of inhibition of PADI1 or PADI1-knockdown on RNA Pol II serine 2 phosphorylation in 
mouse 2- and 4-cell stage embryos. D-Cl-amidine-treated (A), and Padi1-MO injected (B) embryos (collected 
at the 2-cell stage and 4-cell stage separately) were immunostained with anti-RNA Pol II Ser2 (P-Pol II S2) 
and anti-RNA Pol II antibodies, and co-stained with DAPI for DNA. Scale bar, 20 μ m. Representative images 
and quantification of the immunofluorescence signals from each group are shown. At least 40 embryos at each 
stage for each group were analyzed, and the experiments were repeated 3 times. Error bars indicate mean ± SD. 
*P < 0.05 vs. controls.
www.nature.com/scientificreports/
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this discrepancy could be caused by the two different anti-PADI4 antibodies used. We are currently generating 
Padi1-null mouse lines and future studies on the histone citrullination in Padi1 KO mouse oocytes and early 
embryos will help confirm the enzyme activity of PADI1. Given that PADI1 is the only PADI with strong nuclear 
staining from the 2-cell to blastocyst stage, and that PADI3 was not found in the nuclei of early embryos until the 
morula stage (Fig. 1), it seems likely that PADI1, but not the other PADIs, may catalyze these specific citrulline 
modifications on histone tails in early embryos. To further confirm our hypothesis, we have provided two lines 
of evidence: First, zygotes treated with D-Cl-amidine dramatically inhibited histone H3 and H4 citrullination in 
the 2- and 4-cell stage embryos (Fig. 3C,D). Second, injection of Padi1-MO into the zygotes reduced endogenous 
PADI1 (Fig. 2C,D) thus leading to the decreased histone H4Cit3 and H3Cit2/8/17 (Fig. 3E,F) at these two stages. 
Together, we propose that PADI1 localizes in mouse early embryos and contributes to histone H3 and H4 tail 
citrullination.
Unlike the other PADIs, studies on PADI1 are very limited. PADI1 is expressed in a few tissues, including the 
epidermis and uterus, where it is thought to promote the differentiation of keratinocytes by citrullinating the 
intermediate filament, keratin, and filaggrin34–37. However, little else is known regarding the normal and patho-
logical roles of PADI1 in other tissues. This is the first report showing that PADI1 is expressed in early embryos 
and appears to mediate histone citrullination during preimplantation development. Regarding the role of histone 
citrullination on preimplantation development, a previous study has shown that inhibiting histone citrullina-
tion prevented embryo development beyond the 4-cell stage21. Our studies further demonstrate that it is PADI1 
that mediates this modification in the early embryos, and PADI1-catalyzed histone citrullination is vital to early 
embryo progression beyond the 4-cell stage.
During preimplantation development, programmed waves of gene activation may serve to satisfy the develop-
ing embryo’s requirement for specific classes of products at specific times. For example, ZGA transcripts and their 
protein products seem to be required for the progression of embryos beyond the 4-cell stage2,38. Given that his-
tone citrullination of histone H3 and H4 correlates well with gene transactivation16–20, and histone citrullination is 
robustly activated in the nuclei in preimplantation embryos21, it seems likely that decreased histone citrullination 
on H3 and H4 at the 2- and 4-cell stages, due to completely inhibiting or depleting PADI1, may disturb an open 
chromatin structure, prevent a more permissive chromatin state, and inhibit the gene activation required for 
embryo development, thus leading to developmental arrest at the 4-cell stage. Studies are currently underway to 
further identify global gene expression patterns regulated by PADI1 in the early embryos and will fully dissect the 
mechanism by which PADI1 regulates gene expression during mouse preimplantation development.
Materials and Methods
All chemicals and reagents were obtained from Sigma unless otherwise stated. Animal care and experimental 
procedures were approved by the Animal Care and Use Committee of Nanjing Medical University. The study 
protocol was carried out in accordance with institutional guidelines. D-Cl-amidine was synthesized as previously 
described22.
Collection of oocytes, early embryos, and culture of zygotes. Female ICR mice (4–6 weeks) were 
injected intraperitoneally with 10 international units (IU) of pregnant mare serum gonadotropin (PMSG). 
Forty-eight hours later, the mice were sacrificed and the ovaries were isolated and extensively punctured with 
two 30-gauge needles. Immature oocytes displaying germinal vesicle (GV) were collected from ovaries in M2 
medium. For collection of MII oocytes, 6–8-week-old female ICR mice were injected intraperitoneally with 10 IU 
human chorionicgonadotropin (hCG) 48 hours post PMSG injection. 16 hours later, MII oocytes were collected 
after digestion with 0.1% hyaluronidase.
To obtain fertilized oocytes and preimplantation embryos, female mice were mated with 10–12-week-old 
males. Successful mating was confirmed by the presence of vaginal plugs. Zygotes, 2-cell, 4-cell, 8-cell, morula, 
and blastocyst stage embryos were collected 20, 42, 55, 67, 80, and 96 hours post hCG injection, separately.
For early embryos culture, zygotes were collected 20 hours post hCG injection from the ampulla oviducts of 
superovulated females that had been mated with 10–12-week-old males just after injection of hCG. Surrounding 
cumulus cells were dispersed by treatment with 0.1% hyaluronidase for 5 min. Cumulus-free zygotes were washed 
with M2 medium. Embryos were transferred and cultured in fresh KSOM medium (Millipore, MR-020P-D) 
under mineral oil in a 5% CO2 incubator at 37 °C for subsequent development. Then, 2-cell, 4-cell, 8-cell, morula, 
and blastocyst stage embryos were collected after 24, 48, 64, 76, and 100 hours of culture, respectively.
Inhibitor Treatment. D-Cl-amidine was dissolved in PBS. GV oocytes were cultured in M2 medium for 
14 hours (MII oocytes) supplemented with 100 μ M D-Cl-amidine or equal volume of PBS. PN zygotes were cul-
tured in KSOM medium supplemented with 100 μ M D-Cl-amidine or equal volume of PBS for indicated hours 
as states above.
Morpholino (MO) microinjection and in vitro  culture. PADI1-targeting morpholino 
(5′ -GTCGAGCTTCCAGTCTCCTGGTC-3′ ) was purchased from Gene Tools LLC (Philomath, OR, USA), 
and then diluted with water to give a working concentration of 1 mM. About 5 pl morpholino solution was 
microinjected into the zygotes obtained as described above using a Narishige microinjector (Tokyo, Japan). A 
non-targeting MO was injected as a control. After microinjection, zygotes cultured in fresh KSOM medium under 
mineral oil in a 5% CO2 incubator at 37 °C for subsequent development.
Immunofluorescent and confocal microscopy. Oocytes and embryos were fixed in 4% paraformal-
dehyde in PBS (pH 7.4) for 30 min and then permeabilized in 0.5% Triton-X-100 for 30 min at room temper-
ature. After 1 hour blocking in 1% BSA/PBS at room temperature, samples were incubated overnight at 4 °C 
with primary antibodies as following: anti-PADI1 at 1:100 (Cat# HPA028133, Sigma), anti-PADI2 at 1:100 (Cat# 
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12110-1-AP, Proteintech), anti-PADI3 at 1:100 (Cat# ab50246, Abcam), anti-PADI4 at 1:100 (Cat# P4749, Sigma), 
anti-H4Cit3 at 1:50 (Cat# 07-596, Millipore), anti-H3Cit2/8/17 at 1:100 (Cat#ab77164, Abcam), anti-P-Pol II 
S2 at 1:100 (Cat# ab193468, Abcam), anti-Pol II at 1:100 (Cat# sc-12823, Santa Cruz). After five washes, sam-
ples were incubated with FITC-conjugated secondary antibody for 1 hour at room temperature. Nuclei were 
counterstained with DAPI for 5 min. Oocytes and embryos were mounted on glass slides in a drop of antifade 
medium (Vectashield, Burlingame, CA, USA) and examined under confocal laser scanning microscope (LSM 
700; Zeiss, Oberkochen, Germany). Image J software (National Institutes of Health, Bethesda, MD, USA) was 
used to quantify fluorescence intensity. Fluorescence intensity was randomly measured in at least five regions of 
interest strictly limited to the nucleus of each embryo as stated previously39. Fluorescence signal was calculated as 
the average intensity after background subtraction.
Analysis of embryo viability. PN zygotes obtained as described above were cultured for 68 hours in KSOM 
medium supplemented with 100 μ M D-Cl-amidine or equal volume of PBS (controls). Embryos were then incu-
bated with 20 μ g/ml PI in KSOM for 5 min at 37 °C in a 5% CO2 incubator. After 3 washes, embryos were fixed in 
4% paraformaldehyde in PBS for 30 minutes. Finally, oocytes were mounted on glass slides and examined under 
confocal laser scanning microscope. A subset of D-Cl-amidine-treated embryos were permeabilized with 0.1% 
Triton for 20 min prior to PI staining to serve as positive controls.
EU incorporation assays. EU incorporation assays were performed using Click-iT RNA Imaging kits 
(C10329, Invitrogen). PN zygotes were cultured for 21 hours (2-cell embryos) or 45 hours (4-cell embryos) 
in KSOM medium supplemented with 100 μ M D-Cl-amidine or equal volume of PBS (controls). Then 1 mM 
5-ethynyl uridine (EU) was added to the culture for another 3 hours of incubation prior to Hoechst 33342 stain-
ing according to kit instructions. For morpholino-injected embryo culture, PN zygotes injected with Padi1-MO 
or control-MO were cultured for 21 hours (2-cell embryos) or 45 hours (4-cell embryos) in KSOM medium, 
followed by the same EU treatment as above. Images were captured using confocal lasers canning microscope. 
Fluorescence intensity was measured as described above. Fluorescence signal was calculated as the average inten-
sity after background subtraction.
Gene-Specific Expression Analyses. Total RNA was isolated from embryos using Qiagen RNeasy 
Mini Kit in combination with on-column DNase treatment (ABI). High Capacity RNA-to-cDNA kit (ABI) was 
used to synthesize the first strand of cDNA. Quantitative real-time PCR (qPCR) was performed using Power 
SYBR Green PCR Master Mix (ABI) with gene-specific primers. All target gene transcripts were normalized to 
Gapdh. The primers used for the qPCR are Pou5f1 Forward: 5′ -AGAGGATCACCTTGGGGTACA-3′ , Reverse: 
5′ -CGAAGCGACAGATGGTGGTC-3′ ; Eomes Forward: 5′ -GGCCCCTATGGCTCAAATTCC-3′ , Reverse: 
5′ -GAACCACTTCCACGAAAACATTG-3′ ; Crtr-1 Forward: 5′ -CAGCCCGAACACTACAACCAG-3′ , Reverse: 
5′ -CAGCCGGATTTCATACGACTG-3′ ; Utf1f Forward: 5′ -CCGGACCCTTCGATAACCAG-3′ , Reverse: 
5′ -CAGAGTGTCGGTGCTCGTAA-3′ ; Gapdh Forward: 5′ -CTTTGTCAAGCTCATTTCCTGG-3′ , Reverse: 
5′ -TCTTGCTCAGTGTCCTTGC-3′ .
Cell culture and transfection. HEK293 cells were maintained in DMEM supplemented with 10% fetal 
bovine serum. Flag-tagged PADI1, PADI2, and PADI4 in pcDNA3.1 (+ ) or His-tagged PADI1, PADI3 in 
pcDNA3.1 (+ ) plasmids including the empty control vectors were transfected into 293 cells using FuGENE 6 
following the manufacture’s instruction. The cells were collected and lysed 48 hours post transfection for the 
following western blotting assays.
Immunoprecipitation and silver staining. Flag-tagged PADI1 plasmids were transiently transfected 
into HEK293 cells using Fugene6 (Roche). The cells were collected and lysed 48 hours post transfection. The 
whole-cell lysates were immunoprecipitated with anti-Flag M2 affinity gel (#A2220, Sigma) following the manu-
facture’s instruction. Elution of Flag fusion proteins (PADI1) were separated by 10% polyacrylamide gel electro-
phoresis (SDS-PAGE), followed by silver staining using SilverXpress® Silver Staining Kit (#LC6070, Invitrogen).
Acid extraction of histones, PADI assay and western blotting. Cellular histones were purified by 
acid extraction and the PADI assay was performed as described previously21. Briefly, bulk histones were treated 
with Flag-tagged PADI1 in PADI buffer containing 50 mM Tris-HCl (pH 7.6), 4 mM DTT, 4 mM CaCl2 at 37 °C 
for 1 hour. Histone samples were separated by 15% SDS-PAGE and electrically transferred to PVDF membrane. 
The membranes were blocked in 5% milk diluted by TBST for 1 hour at room temperature and then incubated 
overnight at 4 °C with anti-H4Cit3 (1:1000), anti-H3Cit2/8/17 (1:1000) and anti-H4 antibody (1:1000), seperately. 
After 3 washes in TBST, the membranes were incubated for 1 hour with horseradishperoxidase (HRP)-conjugated 
secondary antibody. Specific proteins were detected using ECL Plus Western Blotting Detection System (GE 
Healthcare, Piscataway, NJ, USA).
Statistics. Each experiment was repeated at least three times. All data are presented as mean ± SD, unless 
otherwise indicated. Statistical comparisons were made using Student’s t-test. P < 0.05 was considered to be 
significant.
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